John Carreyrou joins discussion of Nathan Fielder and Lance Oppenheim’s Holmes film

John Carreyrou, the journalist whose Wall Street Journal investigations and book Bad Blood exposed fraud at Theranos, joined a Hard Fork panel to discuss You Can See Everything, the Elizabeth Holmes documentary directed by Nathan Fielder and Lance Oppenheim. The panel video was published on YouTube on Oct. 16, while A24 lists the 2-hour, 55-minute film as opening in theatres that day.

The distinction matters for readers searching for the john carreyrou theranos documentary: the available material establishes that Carreyrou appeared in a discussion about the film. It does not establish that he appears in the documentary or held a role in its production.

According to the Hard Fork episode description, host Max Read was joined by Carreyrou, technology reporter Erin Griffith and New York Times executive producer Caitlin Roper. The programme describes Carreyrou’s reporting for The Wall Street Journal and his book as having revealed the fraud at the centre of Theranos.

Who is John Carreyrou in the Theranos documentary discussion?

Carreyrou is the investigative reporter identified by Hard Fork as having exposed wrongdoing at Theranos through his Wall Street Journal reporting and Bad Blood. His connection to the current release, based on the available evidence, is his participation in the panel discussion alongside Read, Griffith and Roper.

Griffith extensively covered Holmes’s trial, according to the episode description. Roper wrote an early Wired magazine article about Holmes in 2013 before becoming an executive producer at The New York Times.

What is “You Can See Everything” about?

A24’s synopsis says Holmes invited a film crew to follow her 34 days before she was sent to prison. The distributor describes the project as a three-year undertaking and credits Fielder and Oppenheim as its directors.

The film should therefore not be attributed to Fielder alone. Variety also reported that it was co-directed by Fielder and Oppenheim, premiered at the Telluride Film Festival in September 2026 and later screened at the New York Film Festival before its U.S. theatrical opening.

A24’s description is the distributor’s account of the film’s premise, rather than independent verification of the events depicted. The available information supports a narrower conclusion about Carreyrou: he is a panel guest discussing the documentary, with his Theranos credentials rooted in his investigative journalism and book.

This story draws on original reporting from NYT DealBook.